Shuangbing Xu
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 18, 2025
Retraction Note: β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.Yanwei Lu, Xudong Li, Hongli Liu
|Mar 11, 2025
Efficacy and Safety of Third-Generation EGFR-TKIs Combined with Radiotherapy for Advanced NSCLC with Typical EGFR Mutations: A Retrospective Study.Wen-Xuan Zhang, Hui-Chan Xue, Ye Zhao
|Jan 31, 2024
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.Yunshang Chen, Yun Zhou, Xue Feng
|Apr 28, 2023
KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma.Zhen Zeng, Zixuan Li, Jun Xue
|Feb 05, 2022
Targeting KDM4C enhances CD8<sup>+</sup> T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer.Xiaohua Jie, Yunshang Chen, Ye Zhao
|Feb 09, 2021
USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription.Xiaohua Jie, William Pat Fong, Rui Zhou
Pageof 2
